IMMUNOVANT, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.81 USD | +5.34% |
|
+3.73% | -32.61% |
| 03/06 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
| 30/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNOVANT, INC. | Other Biotechnology & Medical Research | +7.35% | +3.73% | -32.61% | +51.41% | +189.99% | 385.92Cr |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMVT Stock
- Charts Immunovant, Inc.
- Comparison Chart
